Medicinova Stock Probability of Future Stock Price Finishing Over 26.81
| MNOV Stock | USD 2.13 0.13 6.50% |
MediciNova |
MediciNova Target Price Odds to finish over 26.81
The tendency of MediciNova Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over $ 26.81 or more in 90 days |
| 2.13 | 90 days | 26.81 | close to zero percent |
Based on a normal probability distribution, the odds of MediciNova to move over $ 26.81 or more in 90 days from now is close to zero percent (This MediciNova probability density function shows the probability of MediciNova Stock to fall within a particular range of prices over 90 days) . Probability of MediciNova price to stay between its current price of $ 2.13 and $ 26.81 at the end of the 90-day period is about 6.11 .
Given the investment horizon of 90 days MediciNova has a beta of -2.27. This indicates as returns on its benchmark rise, returns on holding MediciNova are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, MediciNova is expected to outperform its benchmark. Moreover MediciNova has an alpha of 1.4145, implying that it can generate a 1.41 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). MediciNova Price Density |
| Price |
Predictive Modules for MediciNova
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as MediciNova. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.MediciNova Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. MediciNova is not an exception. The market had few large corrections towards the MediciNova's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold MediciNova, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of MediciNova within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 1.41 | |
β | Beta against Dow Jones | -2.27 | |
σ | Overall volatility | 0.22 | |
Ir | Information ratio | 0.12 |
MediciNova Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of MediciNova for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for MediciNova can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| MediciNova is way too risky over 90 days horizon | |
| MediciNova appears to be risky and price may revert if volatility continues | |
| The company reported the previous year's revenue of 1000 K. Net Loss for the year was (8.57 M) with profit before overhead, payroll, taxes, and interest of 4.04 M. | |
| MediciNova currently holds about 65.23 M in cash with (7.43 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.33. | |
| MediciNova has a poor financial position based on the latest SEC disclosures | |
| Latest headline from gurufocus.com: MediciNova CEO Yuichi Iwaki Provides Corporate Update in Letter to Stockholders |
MediciNova Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of MediciNova Stock often depends not only on the future outlook of the current and potential MediciNova's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. MediciNova's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 49 M | |
| Cash And Short Term Investments | 51 M |
MediciNova Technical Analysis
MediciNova's future price can be derived by breaking down and analyzing its technical indicators over time. MediciNova Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of MediciNova. In general, you should focus on analyzing MediciNova Stock price patterns and their correlations with different microeconomic environments and drivers.
MediciNova Predictive Forecast Models
MediciNova's time-series forecasting models is one of many MediciNova's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary MediciNova's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about MediciNova
Checking the ongoing alerts about MediciNova for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for MediciNova help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| MediciNova is way too risky over 90 days horizon | |
| MediciNova appears to be risky and price may revert if volatility continues | |
| The company reported the previous year's revenue of 1000 K. Net Loss for the year was (8.57 M) with profit before overhead, payroll, taxes, and interest of 4.04 M. | |
| MediciNova currently holds about 65.23 M in cash with (7.43 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.33. | |
| MediciNova has a poor financial position based on the latest SEC disclosures | |
| Latest headline from gurufocus.com: MediciNova CEO Yuichi Iwaki Provides Corporate Update in Letter to Stockholders |
Additional Tools for MediciNova Stock Analysis
When running MediciNova's price analysis, check to measure MediciNova's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MediciNova is operating at the current time. Most of MediciNova's value examination focuses on studying past and present price action to predict the probability of MediciNova's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MediciNova's price. Additionally, you may evaluate how the addition of MediciNova to your portfolios can decrease your overall portfolio volatility.